Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013

Highlights • FMP013 in ALFQ adjuvant induced a strong antibody and protective response in mice. • ALFQ was a more potent adjuvant than Montanide ISA 720. • ALFQ enhanced IgG2c, germinal center B-cells and antibody secreting cells. • ALFQ enhanced T-cell responses in a TH 1 biased manner. • FMP013 +...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2017-07, Vol.35 (31), p.3865-3874
Hauptverfasser: Genito, Christopher J, Beck, Zoltan, Phares, Timothy W, Kalle, Fanta, Limbach, Keith J, Stefaniak, Maureen E, Patterson, Noelle B, Bergmann-Leitner, Elke S, Waters, Norman C, Matyas, Gary R, Alving, Carl R, Dutta, Sheetij
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • FMP013 in ALFQ adjuvant induced a strong antibody and protective response in mice. • ALFQ was a more potent adjuvant than Montanide ISA 720. • ALFQ enhanced IgG2c, germinal center B-cells and antibody secreting cells. • ALFQ enhanced T-cell responses in a TH 1 biased manner. • FMP013 + ALFQ is under consideration for a human malaria vaccine trial.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2017.05.070